<?xml version="1.0" encoding="ISO-8859-1"?>










<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:html="http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<channel>
<atom:link href="http://www.theheart.org/rssfeed.do" rel="self" type="application/rss+xml" />
<title>theHeart.org</title>
<link>http://www.theheart.org/</link>
<description></description>
<image>
 <url>http://www.theheart.org/documents/sitestructure/resources/images/maintho_logo_rss.png</url>
 <title>theHeart.org</title>
 <link>http://www.theheart.org/</link>
</image>




	<item>
	<link>http://www.theheart.org/article/983741.do</link>
	<title>ACC aghast at proposed cuts to cardiology payments in Medicare physician fee schedule for 2010</title>
	<description>
	
	   <![CDATA[ The CMS announced its planned 2010 Medicare Physician Fee Schedule this week, which includes proposals that could result in cuts ranging from 10% to more than 40% in Medicare payments for various cardiology services, says the ACC.  ]]>
	
	</description>
	<pubDate>
	, 03  2009 14:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983741.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983491.do</link>
	<title>Warnings for smoking-cessation drugs varenicline, bupropion </title>
	<description>
	
	   <![CDATA[ Smoking-cessation drugs varenicline and bupropion must carry a boxed warning in their labeling stating that use of the drugs has been associated with serious mental-health events, the US FDA has announced. ]]>
	
	</description>
	<pubDate>
	Ϋ, 02  2009 12:45:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983491.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983519.do</link>
	<title>FDA approves dronedarone for atrial fibrillation</title>
	<description>
	
	   <![CDATA[ Dronedarone is envisioned as a safer alternative to amiodarone, a widely used antiarrhythmic agent in patients with AF. ]]>
	
	</description>
	<pubDate>
	Ϋ, 02  2009 11:45:49 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983519.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983447.do</link>
	<title>ARMYDA-RECAPTURE published: Statin reload before PCI</title>
	<description>
	
	   <![CDATA[ The rate of major adverse cardiac events was significantly lower among patients "reloaded" with atorvastatin 80 mg 12 hours prior to PCI and 40 mg just before the procedure than in those who did not receive the additional statin boost. ]]>
	
	</description>
	<pubDate>
	Ϋ, 02  2009 11:30:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983447.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983391.do</link>
	<title>Survival after in-hospital CPR static since 1992 </title>
	<description>
	
	   <![CDATA[ An analysis of Medicare records for over 433 000 patients who received CPR between 1992 and 2005 showed that the rate of survival to hospital discharge hovered at around 18%, in spite of efforts to improve CPR delivery.  ]]>
	
	</description>
	<pubDate>
		, 01  2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983391.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983205.do</link>
	<title>Progenitor cells identified from human fetal hearts </title>
	<description>
	
	   <![CDATA[ Human cardiovascular progenitor cells isolated from human fetal hearts can give rise to striated- and smooth-muscle cells as well as endothelial cells, researchers report. ]]>
	
	</description>
	<pubDate>
		, 01  2009 13:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983205.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983185.do</link>
	<title>Barriers to optimal termination of resuscitation in out-of-hospital cardiac arrest identified</title>
	<description>
	
	   <![CDATA[ Insurance-reimbursement rules, state laws, and the public's false perceptions of survival after cardiac arrest may impede emergency medical workers from using best resuscitation attempts, a study finds.  ]]>
	
	</description>
	<pubDate>
		, 01  2009 10:30:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983185.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982959.do</link>
	<title>New meta-analysis: Statins of benefit in primary prevention </title>
	<description>
	
	   <![CDATA[ A new meta-analysis including some of the more contemporary statin trials has found that the agents significantly improve survival and reduce coronary and cardiovascular end points in primary-prevention populations, a benefit that extends to all subgroups. But the exact cost/benefit equation for each group remains to be determined.  ]]>
	
	</description>
	<pubDate>
	, 30 m 2009 19:01:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982959.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982851.do</link>
	<title>CRP, other biomarkers, not clinically useful to predict CVD risk </title>
	<description>
	
	   <![CDATA[ Screening for contemporary biomarkers, such as CRP, will not add much to conventional cardiovascular risk factors in terms of helping to predict future events in the primary-prevention setting, say the authors of a new study.  ]]>
	
	</description>
	<pubDate>
	, 30 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982851.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/983133.do</link>
	<title>Alogliptin delayed; cancer concerns with insulin glargine</title>
	<description>
	
	   <![CDATA[ The makers of alogliptin say it will be two years before they have the cardiovascular data needed by the FDA, while the EASD raises concerns over a possible cancer risk with insulin glargine. ]]>
	
	</description>
	<pubDate>
	, 30 m 2009 15:15:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/983133.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982997.do</link>
	<title>Cardiac rhythms synchronize with music </title>
	<description>
	
	   <![CDATA[ Music, particularly pieces that contain crescendos or gradual increases in volume, elicits synchronized cardiovascular and respiratory responses in young people, a new study finds. ]]>
	
	</description>
	<pubDate>
	, 30 m 2009 14:45:55 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982997.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982827.do</link>
	<title>Anxiety, depression, linked to angina frequency</title>
	<description>
	
	   <![CDATA[ New research shows that ischemic heart disease patients who suffer significant anxiety have close to a fivefold increased risk of experiencing frequent angina and those with depression have more than a threefold increased risk for these episodes.   ]]>
	
	</description>
	<pubDate>
	, 30 m 2009 10:45:20 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982827.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982755.do</link>
	<title>Mainly medical unknowns regarding Michael Jackson&#39;s apparent cardiac arrest</title>
	<description>
	
	   <![CDATA[ With concerns raised about the use of prescription painkillers in Jackson's death, as well as the stress he was under with an impending world tour, Dr Douglas Zipes, from the ACC, and Dr Vinay Nadkarmi, from the AHA, both weigh in on some of the speculation for <b>heart</b><b><i>wire</i></b>.  ]]>
	
	</description>
	<pubDate>
	 , 29 m 2009 17:45:17 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982755.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982711.do</link>
	<title>Massive vitamin-D/omega-3 trial for CVD, cancer prevention </title>
	<description>
	
	   <![CDATA[ Study participants will be randomized to one of four groups: daily vitamin D (2000 IU) and fish oil (1 g); daily vitamin D and fish-oil placebo; daily vitamin-D placebo and fish oil; or daily vitamin-D placebo and fish-oil placebo and followed for five years. ]]>
	
	</description>
	<pubDate>
	 , 29 m 2009 17:00:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982711.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982461.do</link>
	<title>Wolves in sheep&#39;s clothing: Don&#39;t ignore white-coat and masked hypertension </title>
	<description>
	
	   <![CDATA[ White-coat hypertension and masked hypertension should not be regarded as benign, say the authors of a new 10-year study. The risk of developing sustained hypertension is higher in people with the above two conditions than in those who have normal blood pressure, they found. ]]>
	
	</description>
	<pubDate>
	 , 29 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982461.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982403.do</link>
	<title>Cardiologist gets 10 years for performing unnecessary interventions</title>
	<description>
	
	   <![CDATA[ Mehmood Patel, an interventional cardiologist from Louisiana, has been sentenced to 10 years in prison for performing unnecessary invasive interventional procedures and falsifying patient records.  ]]>
	
	</description>
	<pubDate>
	, 26 m 2009 15:45:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982403.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982341.do</link>
	<title>CVD risks of HIV infection underestimated</title>
	<description>
	
	   <![CDATA[ HIV infection per se is an independent risk factor for preclinical atherosclerosis, with the magnitude of the effect being similar to that of known risk factors, such as smoking and diabetes, a new study has shown.  ]]>
	
	</description>
	<pubDate>
	, 26 m 2009 12:00:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982341.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982213.do</link>
	<title>Michael Jackson dies of cardiac arrest </title>
	<description>
	
	   <![CDATA[ Jackson, who was 50, was pronounced dead at UCLA medical center mid-afternoon, Pacific Time.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 21:30:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982213.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982163.do</link>
	<title>CT-angiography-identified vulnerable plaque associated with higher risk of ACS</title>
	<description>
	
	   <![CDATA[ Identifying these unstable coronary plaques could be used to aggressively treat patients who are at higher risk for future events, according to researchers. There are skeptics, however, and at present even researchers concede there are no different preventive measures available to treat those with high-risk lesions.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 17:00:49 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982163.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982117.do</link>
	<title>Frequent migraine with aura linked to stroke, lower frequency with MI and revascularization</title>
	<description>
	
	   <![CDATA[ Researchers are reporting divergent patterns of cardiovascular events associated with the frequency of migraine attacks with aura: more frequent attacks are associated with higher stroke risk, lower frequencies with higher MI and revascularization.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 16:15:28 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982117.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982093.do</link>
	<title>Moderate wine, little meat, many vegetables may be key Mediterranean diet items linked to longer life </title>
	<description>
	
	   <![CDATA[ A population-based cohort study of individuals in Greece has teased out items in the Mediterranean diet that appear to contribute to the increased longevity associated with this diet.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 14:30:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982093.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/982027.do</link>
	<title>TRANSFER AMI published: Finding the optimal window for PCI postlysis </title>
	<description>
	
	   <![CDATA[ Experts suggest that early PCI is beneficial in STEMI patients already treated with fibrinolysis, as long as it is performed at least two hours after the lytic is given.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 13:45:06 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/982027.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981901.do</link>
	<title>Novel processing technique &quot;freezes&quot; cardiac motion during PET imaging</title>
	<description>
	
	   <![CDATA[ High-definition PET plus "motion-frozen" imaging technology yields ultraclear pictures of the heart to enhance the diagnosis of myocardial defects. ]]>
	
	</description>
	<pubDate>
	Ϋ, 25 m 2009 11:30:14 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981901.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981815.do</link>
	<title>Intensive LDL lowering improves carotid plaque stability</title>
	<description>
	
	   <![CDATA[ Investigators report that echogenicity, an ultrasound-based measure of plaque stability, was significantly improved among patients treated to very low LDL-cholesterol levels. ]]>
	
	</description>
	<pubDate>
		, 24 m 2009 16:30:48 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981815.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981789.do</link>
	<title>Wide variations in EP practice across Europe </title>
	<description>
	
	   <![CDATA[ The way in which arrhythmias are treated varies greatly across Europe, a new survey of 40 countries has shown.  ]]>
	
	</description>
	<pubDate>
		, 24 m 2009 15:30:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981789.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981553.do</link>
	<title>MADIT-CRT results: CRT-D reduces mortality and morbidity in NYHA 1 or 2 HF</title>
	<description>
	
	   <![CDATA[ As announced by Boston Scientific today, so only the most preliminary data are currently available, CRT-D reduced death or heart-failure hospitalizations 29% compared with ICD therapy alone. ]]>
	
	</description>
	<pubDate>
	, 23 m 2009 16:45:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981553.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981659.do</link>
	<title>PR-interval prolongation increases risk of atrial fibrillation and pacemaker implantation</title>
	<description>
	
	   <![CDATA[ These new findings, according to investigators, challenge previously held assumptions that PR prolongation or first-degree atrioventricular block is a benign prognosis. ]]>
	
	</description>
	<pubDate>
	, 23 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981659.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981413.do</link>
	<title>Heart-attack prevention bill, mandating coverage for CAD screening, passes quietly in Texas </title>
	<description>
	
	   <![CDATA[ <b><i>U</i></b><b><i>PDATED</i></b><i> // </i>After a rocky ride in and out of the Texas legislature (twice) and most recently a perplexing pairing with bariatric surgery, the bill is now poised to become law September 1. ]]>
	
	</description>
	<pubDate>
	, 23 m 2009 15:30:41 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981413.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981469.do</link>
	<title>More details on arrhythmias associated with sleep apnea </title>
	<description>
	
	   <![CDATA[ A new study has found that increasing severity of sleep apnea is associated with a progressive increase in the risk of nocturnal arrhythmias. In addition, different types of sleep apnea were associated with different kinds of arrhythmias.  ]]>
	
	</description>
	<pubDate>
	, 23 m 2009 14:45:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981469.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981347.do</link>
	<title>Similar success, survival at PCI centers with and without surgical backup: NCDR data in print </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED </i></b>// One of the authors on a new registry analysis says the findings are persuasive: possibly enough to persuade guideline-writing groups to reconsider the class 3 recommendation against performing elective PCI without surgical backup.  ]]>
	
	</description>
	<pubDate>
	, 23 m 2009 12:15:57 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981347.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980589.do</link>
	<title>CV mortality and hospitalizations declining in Canada</title>
	<description>
	
	   <![CDATA[ From 1994 to 2004, cardiovascular disease mortality declined 30%, while the rate of MI mortality decreased 38.1% and stroke mortality decreased 28.2%. ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 16:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980589.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981169.do</link>
	<title>Intensive smoking-cessation program can double quit rate in cardiac patients </title>
	<description>
	
	   <![CDATA[ Patients hospitalized for CABG or MI were twice as likely to successfully quit smoking if they received intensive counseling in the hospital with follow-up support after discharge, in a recent study.  ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 16:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981169.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981241.do</link>
	<title>&quot;Natural&quot; ED product recalled; contains PDE-5 inhibitor </title>
	<description>
	
	   <![CDATA[ People taking the nonprescription dietary supplement marketed under the name Stamina-Rx "should stop using it immediately," the FDA is warning consumers.   ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981241.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980875.do</link>
	<title>ESC issues statement on driving restrictions for ICD patients </title>
	<description>
	
	   <![CDATA[ Hopes are that the recommendations will help European governments standardize such restrictions across Europe.  ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980875.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981197.do</link>
	<title>More patients at LDL targets, but improvement still needed</title>
	<description>
	
	   <![CDATA[ Compared with a decade ago, where just 38% achieved LDL-cholesterol guideline targets, 73% of individuals are now at goal. ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981197.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/981121.do</link>
	<title>Psoriasis associated with all vascular disease </title>
	<description>
	
	   <![CDATA[ As well as being an independent risk factor for cardiovascular disease, psoriasis is also associated with an increased risk of cerebrovascular disease and peripheral arterial disease, a new case-control study has shown. ]]>
	
	</description>
	<pubDate>
	 , 22 m 2009 13:45:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/981121.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980985.do</link>
	<title>CT angiography does not reliably predict functional significance of lesions </title>
	<description>
	
	   <![CDATA[ Investigators say that a diagnostic strategy relying on CTA alone should not be used for making revascularization decisions. An editorial accompanying the study echoes the group's conclusions.  ]]>
	
	</description>
	<pubDate>
	, 19 m 2009 17:45:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980985.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980945.do</link>
	<title>Framingham analysis: Look beyond LVEF in heart-failure management </title>
	<description>
	
	   <![CDATA[ Is it limiting to categorize heart failure simply in terms of low or preserved LVEF? An analysis points to a constellation of features apparent at the time of heart-failure onset that suggest a likelihood of preserved-LVEF heart failure and that may be etiologic and potentially modifiable.   ]]>
	
	</description>
	<pubDate>
	, 19 m 2009 17:30:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980945.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980779.do</link>
	<title>EMEA issues warning on possible clopidogrel-PPI interaction, but is there really a problem? </title>
	<description>
	
	   <![CDATA[ The European Medicines Agency has now followed suit with the US FDA and issued a warning discouraging concomitant use of clopidogrel and PPIs, but some experts believe the issue has been overhyped.  ]]>
	
	</description>
	<pubDate>
	, 19 m 2009 14:00:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980779.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980667.do</link>
	<title>Uncertainty remains as to whether genetic testing for VTE improves outcomes </title>
	<description>
	
	   <![CDATA[ It remains unknown whether genetic testing for two prothrombotic mutations improves outcomes for patients with venous thromboembolism or for family members of those with mutations, a new review concludes.  ]]>
	
	</description>
	<pubDate>
	, 19 m 2009 12:00:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980667.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980327.do</link>
	<title>New low-cost, solar-powered BP device for developing countries </title>
	<description>
	
	   <![CDATA[ A new, low-cost, solar-powered blood-pressure-monitoring device has been shown to be accurate and easy to use and was well accepted by healthcare professionals and patients in a field trial in Africa. This could be a "critical tool" in tackling the global problem of hypertension, said one expert.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 18 m 2009 15:15:52 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980327.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980251.do</link>
	<title>Early natriuretic-peptide level changes seen to predict late acute-HF outcomes</title>
	<description>
	
	   <![CDATA[ A drop in BNP over the first few hospitalization days independently predicted survival gains over six months in a post hoc analysis from a randomized trial. Researchers say it's time for a prospective trial in acute decompensated heart failure testing the value of treatment aimed specifically at pushing down natriuretic-peptide levels.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 18 m 2009 14:15:01 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980251.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980073.do</link>
	<title>A Portuguese success story: One nation begins to curb its salt intake </title>
	<description>
	
	   <![CDATA[ Doctors from the Portuguese Society of Hypertension have spearheaded a unique mass-media campaign about the harmful consequences of consuming too much salt, which in turn has led to the Portuguese Parliament approving a law restricting the sodium content of processed foods.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 18 m 2009 10:00:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980073.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980053.do</link>
	<title>FDA urges caution in interpreting study linking stimulants to increased risk for sudden death in children</title>
	<description>
	
	   <![CDATA[ Study limitations mean it should not serve as a basis for decision to stop a child's stimulant meds, agency says.  ]]>
	
	</description>
	<pubDate>
		, 17 m 2009 17:00:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980053.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/980001.do</link>
	<title>Published ATLAS ACS-TIMI 46 results for rivaroxaban pave the way for phase 3 trial </title>
	<description>
	
	   <![CDATA[ Investigators say results from this phase 2, dose-escalation study have paved the way for the phase 3 trial, ATLAS ACS 2,  already enrolling patients and using the lower two doses, twice daily, identified as having the most desirable risk/benefit profile in the phase 2 study.   ]]>
	
	</description>
	<pubDate>
		, 17 m 2009 14:30:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/980001.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979943.do</link>
	<title>NT-proBNP proposed for LVD screening in patients at high risk for heart failure </title>
	<description>
	
	   <![CDATA[ The natriuretic peptide had a very high negative predictive value for identifying LV dysfunction in asymptomatic diabetics and hypertensives in an observational study.   ]]>
	
	</description>
	<pubDate>
		, 17 m 2009 13:00:43 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979943.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979773.do</link>
	<title>Exercise training boosts benefits of cardiac resynchronization therapy</title>
	<description>
	
	   <![CDATA[ The addition of an exercise program yielded improved functional and hemodynamic changes on top of those already observed with biventricular pacing, prompting investigators to suggest it is reasonable to provide exercise training to all patients after CRT. ]]>
	
	</description>
	<pubDate>
	, 16 m 2009 17:45:20 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979773.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979673.do</link>
	<title>Darusentan data encouraging but &quot;very, very early&quot; </title>
	<description>
	
	   <![CDATA[ A phase 3 study with darusentan in patients with resistant hypertension was encouraging, but the data are still "very, very early," said the researcher who presented the late-breaking trial at the European Hypertension meeting this weekend.  ]]>
	
	</description>
	<pubDate>
	, 16 m 2009 14:30:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979673.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979565.do</link>
	<title>theheart.org editor wins NIHCM journalism award </title>
	<description>
	
	   <![CDATA[ <b>Shelley Wood</b>, managing editor of <b>theheart.org</b>, has won a 2009 National Institute for Health Care Management Journalism and Research Award for her "Myxo ring mix-up" series. ]]>
	
	</description>
	<pubDate>
	, 16 m 2009 13:00:24 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979565.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979249.do</link>
	<title>DES &quot;noninferior&quot; to MIDCAB for isolated LAD disease, small study suggests </title>
	<description>
	
	   <![CDATA[ Repeat procedures were more common for PCI, while periprocedural events were more common in the MIDCAB group, investigators report.  ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979249.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979385.do</link>
	<title>Red yeast rice reduces LDL-cholesterol levels in statin-intolerant patients</title>
	<description>
	
	   <![CDATA[ Although the popular herbal supplement might provide a future treatment alternative for these difficult-to-treat patients, investigators noted the lack of chemical consistency between different manufacturers and a need for better regulation from the Food and Drug Administration. ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979385.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978957.do</link>
	<title>HCTZ a &quot;paltry&quot; antihypertensive, with no effect on outcomes, new analysis suggests </title>
	<description>
	
	   <![CDATA[ The lead investigator for a controversial new analysis of hydrochlorothiazide says the drug is a "paltry" antihypertensive at the usual doses prescribed (12.5 mg-25 mg/per day) and should not be used as initial therapy. Others, however, offered plenty of caveats for the "provocative" conclusions.  ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 15:00:45 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978957.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979165.do</link>
	<title>GLP-1 analog outperforms sulfonylurea in type 2 diabetes</title>
	<description>
	
	   <![CDATA[ In a head-to-head comparison, liraglutide reduced A<sub>1C</sub> levels more effectively with virtually no hypoglycemia and with weight loss, compared with weight gain with glimepiride. ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 13:15:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979165.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979129.do</link>
	<title>Proinflammatory and prothrombotic markers seen in obese kids with no other metabolic syndrome risk factors </title>
	<description>
	
	   <![CDATA[ Obese children, even those without blood-pressure, lipid, or glucose abnormalities, have significantly higher levels of insulin, adiponectin, fibrinogen, and CRP than lean, age-matched controls, a new study suggests.  ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 12:00:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979129.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/979043.do</link>
	<title>Some surprises in update to European hypertension guidelines? </title>
	<description>
	
	   <![CDATA[ The European Society of Hypertension is set to stir up the field of BP guidelines later this year, when it publishes an update to its 2007 recommendations. One key change is the recognition of a level of blood pressure below which could be dangerous to high-risk individuals, the so-called J-curve phenomenon. And the new guidelines will advise tailoring therapy to individual patients, rather than recommending a first-, second- and third-line drug therapy approach.  ]]>
	
	</description>
	<pubDate>
	 , 15 m 2009 11:15:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/979043.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978833.do</link>
	<title>Chronic corticosteroid use a risk factor for CV events in kidney graft recipients </title>
	<description>
	
	   <![CDATA[ The incidence of cardiovascular events was lower in the steroid-withdrawal group compared with the chronic-corticosteroid group; other risk factors were also identified. ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 17:15:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978833.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978773.do</link>
	<title>Paclitaxel-eluting stents may be safe, effective in certain elderly patients</title>
	<description>
	
	   <![CDATA[ A study suggests that paclitaxel-eluting stents may be a safe, effective treatment of coronary artery disease in patients 70 years and older and that they should not be withheld based on patient age. ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 16:30:28 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978773.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978691.do</link>
	<title>Medtronic pacemaker advisory now a class-1 recall </title>
	<description>
	
	   <![CDATA[ The wire-separation issues in some of Medtronic's Kappa and Sigma pacemakers, which the company warned physicians about last month, may warrant device replacement in patients who are pacemaker dependent, according to the company.  ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 13:45:13 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978691.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978667.do</link>
	<title>Beta-blocker benefit in SENIORS independent of LVEF</title>
	<description>
	
	   <![CDATA[ Heart-failure patients at least 70 years old who took nebivolol in the randomized trial had similar reductions in all-cause mortality or CV hospitalization, whether their LVEF was below or above 35%. ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 13:15:32 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978667.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978619.do</link>
	<title>More evidence links glitazones to broken bones </title>
	<description>
	
	   <![CDATA[ The largest study to date looking at whether the risk of bone fractures is increased in the setting of thiazolidinedione drugs suggests that fracture risk is more than 40% higher in people taking TZDs and that both men and women are vulnerable.  ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 12:45:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978619.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978589.do</link>
	<title>Enrollment resumes for CHD chelation-therapy trial </title>
	<description>
	
	   <![CDATA[ The<b> </b>Trial to Assess Chelation Therapy, a randomized, placebo controlled study of EDTA for post-MI patients, had halted enrollment last year amid controversy.   ]]>
	
	</description>
	<pubDate>
	, 12 m 2009 11:45:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978589.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978551.do</link>
	<title>Health concerns real for the overweight, especially if other risk factors present, says AHA  </title>
	<description>
	
	   <![CDATA[ The health hazards of being overweight&#151;as distinct from being obese&#151;are real and should be taken seriously, especially if other risk factors are present, such as glucose intolerance or elevated blood pressure, concludes a new scientific advisory from the American Heart Association.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 11 m 2009 17:15:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978551.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978531.do</link>
	<title>&quot;Eco-Atkins&quot; plant-based, low-carb diet appears to lower cholesterol </title>
	<description>
	
	   <![CDATA[ Weight loss was similar, but serum lipid levels were better after one month on a low-carb, plant-based diet vs a high-carb, lacto-ovo vegetarian diet, in a small study of overweight adults with hyperlipidemia.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 11 m 2009 17:00:52 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978531.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978435.do</link>
	<title>Preoperative status predicts success of infrainguinal bypass for PAD  </title>
	<description>
	
	   <![CDATA[ PAD patients who were not able to perform activities of daily living independently had a higher incidence of death and major complications following lower bypass surgery, a new study has found. A simple preoperative assessment of functional status may therefore help to identify those who are unsuitable for surgery, say the researchers.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 11 m 2009 14:00:36 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978435.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978399.do</link>
	<title>Success, complication rates for ablation therapy of atrial fib are consistent in meta-analysis </title>
	<description>
	
	   <![CDATA[ Recent trials and the published literature all send the same message about ablation for atrial fibrillation, researchers say: it's a good therapy but doesn't work all the time and should be reserved for patients who don't respond to multiple drug trials.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 11 m 2009 12:00:53 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978399.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978347.do</link>
	<title>Genetic predisposition plus use of ACE-activity-lowering drugs may increase suicide risk in men</title>
	<description>
	
	   <![CDATA[ Men with a genotype for low ACE activity appear to have an increased risk of suicide, and ACE inhibitors may worsen that risk. But researchers say the findings should be interpreted with caution.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 11 m 2009 09:45:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978347.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978157.do</link>
	<title>A good night&#39;s sleep associated with reduced blood pressure </title>
	<description>
	
	   <![CDATA[ More evidence that a good night's sleep is associated with a better blood-pressure profile has come from a new study.  ]]>
	
	</description>
	<pubDate>
		, 10 m 2009 17:00:45 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978157.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/978067.do</link>
	<title>Intensive glycemic control not directly linked to excess cardiovascular risk</title>
	<description>
	
	   <![CDATA[ ACCORD's early findings of a link between low A<sub>1C</sub> level and increased risk of cardiovascular death do not hold up under analysis; the link is not causal. ]]>
	
	</description>
	<pubDate>
		, 10 m 2009 15:00:23 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/978067.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977905.do</link>
	<title>Proton-pump inhibitors blunt efficacy of clopidogrel in diabetics with coronary stents</title>
	<description>
	
	   <![CDATA[ PPIs increase the risk of cardiovascular events 44% in diabetics with stents on clopidogrel. ]]>
	
	</description>
	<pubDate>
		, 10 m 2009 12:00:54 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977905.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977793.do</link>
	<title>Simple steps can reduce radiation dose with CT angiography </title>
	<description>
	
	   <![CDATA[ Researchers say that very simple steps can reduce radiation dose by more than 50%, without investing in some of the newer machines that have incorporated dose-reducing technology. But they also caution that centers performing CT angiography may not realize just how much radiation they are giving their patients. ]]>
	
	</description>
	<pubDate>
		, 10 m 2009 11:00:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977793.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977667.do</link>
	<title>New data show that Lp(a) is a causal factor for MI, researchers say </title>
	<description>
	
	   <![CDATA[ A new study examining genetic data from three different trials shows unequivocally that lipoprotein (a) is a causal factor for MI. The findings elevate the status of Lp(a) from a putative risk marker to a confirmed causal factor, says an accompanying editorial.   ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 17:30:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977667.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977595.do</link>
	<title>Pioglitazone slows progression of carotid atherosclerosis </title>
	<description>
	
	   <![CDATA[ Carotid artery intima media thickness was 38% lower in subjects taking pioglitazone compared with those taking placebo in the diabetes-prevention trial ACTOS Now.  ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 14:45:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977595.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977529.do</link>
	<title>Once-weekly exenatide achieves better glycemic control than daily sitagliptin or pioglitazone</title>
	<description>
	
	   <![CDATA[ The investigational glucagonlike peptide-1 receptor agonist exenatide lowers hemoglobin A<sub>1C</sub> levels to a greater extent; more patients with type 2 diabetes reached A<sub>1C</sub> targets. ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 14:00:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977529.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977461.do</link>
	<title>Ray of hope for customizable-length DES </title>
	<description>
	
	   <![CDATA[ In what may yet prove to be the deus ex machina for beleaguered Xtent, the FDA has conditionally approved the launch of the CUSTOM IV and CUSTOM IV Angio trials.  ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 12:00:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977461.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977371.do</link>
	<title>LEAD 6: Greater A1C drop with liraglutide than exenatide in type 2 diabetes </title>
	<description>
	
	   <![CDATA[ The investigational glucagonlike peptide-1 (GLP-1) analog is also associated with more weight loss and better tolerability than the already-on-the-market GLP-1 receptor blocker exenatide.  ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 11:45:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977371.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977187.do</link>
	<title>AHA urges exercise to cut CV risk in diabetics</title>
	<description>
	
	   <![CDATA[ The recommendation is for at least 150 minutes per week of aerobic exercise, plus resistance training.   ]]>
	
	</description>
	<pubDate>
	, 09 m 2009 09:45:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977187.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976903.do</link>
	<title>Milestone paper: First 5-year data on stem-cell treatment in AMI </title>
	<description>
	
	   <![CDATA[ The first long-term results of autologous bone-marrow-cell transplantation to treat patients with acute MI show it to be safe and to offer a small improvement in cardiac function. The findings also hint at a survival benefit for those treated with the bone-marrow cells. However, many issues remain to be addressed before this therapy reaches its much-anticipated potential, says an accompanying editorial.  ]]>
	
	</description>
	<pubDate>
	 , 08 m 2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976903.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977153.do</link>
	<title>FDA approval requested for Crestor-Trilipix combo </title>
	<description>
	
	   <![CDATA[ If the agency agrees, the companies will market the new drug as Certriad. ]]>
	
	</description>
	<pubDate>
	 , 08 m 2009 16:45:04 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977153.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/977117.do</link>
	<title>Half of strokes early after TIA occur within 24 hours</title>
	<description>
	
	   <![CDATA[ A new study shows that about half of all strokes that occur in the first week after a transient ischemic attack actually occur within the first 24 hours, highlighting the need for emergent intervention, the researchers say. ]]>
	
	</description>
	<pubDate>
	 , 08 m 2009 16:15:35 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/977117.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976995.do</link>
	<title>No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D</title>
	<description>
	
	   <![CDATA[ Overall rates of major CV events also were no different between revascularization and medical therapy, although CABG alone&#151;but not PCI&#151;was associated with a reduction in the risk of cardiovascular events, particularly nonfatal MI, compared with medical therapy, investigators note.  ]]>
	
	</description>
	<pubDate>
	 , 08 m 2009 13:35:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976995.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976685.do</link>
	<title>Avandia on the RECORD: No &quot;overall&quot; CV risk increase, but trial remains controversial </title>
	<description>
	
	   <![CDATA[ The trial concluded with the rosiglitazone being "noninferior" to metformin/sulfonylurea therapy with respect to CV death or hospitalization as adverse events over a follow-up of about five years. Researchers and observers disagree sharply, however, over what those results and other findings in the trial mean for diabetes therapy.  ]]>
	
	</description>
	<pubDate>
	, 05 m 2009 19:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976685.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976335.do</link>
	<title>Newly minted FDA commissioner gets an earful of prasugrel </title>
	<description>
	
	   <![CDATA[ An outspoken critic of the drug's most supportive study and a well-known public advocacy group have coauthored a letter to regulators urging a halt to their review of prasugrel's approval application. ]]>
	
	</description>
	<pubDate>
		, 03 m 2009 17:00:27 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976335.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976255.do</link>
	<title>Parathyroid hormone levels predict CV mortality in the community </title>
	<description>
	
	   <![CDATA[ A new analysis of a Swedish study<b> </b>of<b> </b>elderly men has found that plasma parathyroid hormone levels predict cardiovascular mortality, even in those with normal levels of this hormone. The risk remained after multivariate adjustment and was similar to that seen for other classical risk factors and so could have substantial public-health implications, say the researchers.  ]]>
	
	</description>
	<pubDate>
		, 03 m 2009 14:45:54 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976255.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/976027.do</link>
	<title>Hypertension well-controlled in medically complex patients </title>
	<description>
	
	   <![CDATA[ A new study has found that patients with the most complex medical conditions got the best care for their hypertension. The researchers say that these results should allay concerns that pay-for-performance and other reports act as disincentives to treat the sickest patients.  ]]>
	
	</description>
	<pubDate>
		, 03 m 2009 11:30:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/976027.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975967.do</link>
	<title>Meta-analysis questions use of aspirin in primary prevention </title>
	<description>
	
	   <![CDATA[ Results of a new meta-analysis "do not seem to justify general guidelines advocating the routine use of aspirin in all healthy individuals above a moderate level of risk for coronary heart disease."  ]]>
	
	</description>
	<pubDate>
		, 03 m 2009 10:15:32 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975967.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975907.do</link>
	<title>FDA rejects application of beta blocker intended for genotype-guided heart-failure therapy </title>
	<description>
	
	   <![CDATA[ Regulators have told Arca Biopharma that bucindolol isn't approvable without, among other things, the completion of an additional efficacy trial that includes an all-cause mortality end point, the company says.  ]]>
	
	</description>
	<pubDate>
	, 02 m 2009 17:00:42 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975907.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975879.do</link>
	<title>Rapid growth in infancy linked to cardiovascular and metabolic risk factors later in life</title>
	<description>
	
	   <![CDATA[ Increased weight gain relative to height in early infancy is associated with reduced insulin sensitivity and serum HDL-cholesterol levels, as well as increased waist circumference and serum triglyceride levels, report investigators. ]]>
	
	</description>
	<pubDate>
	, 02 m 2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975879.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975707.do</link>
	<title>PEPCAD-2 ISR drug-coated balloon study now published</title>
	<description>
	
	   <![CDATA[ Investigators say the drug-coated balloon is potentially cheaper and is associated with a shorter duration of clopidogrel therapy, which would increase safety. ]]>
	
	</description>
	<pubDate>
	, 02 m 2009 14:00:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975707.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975593.do</link>
	<title>Six generic clopidogrel versions pass first EU marketing hurdle </title>
	<description>
	
	   <![CDATA[ The European Medicines Agency has given the green light to six generic versions of clopidogrel, which means that the products could be available in a number of European Union countries within a few months.  ]]>
	
	</description>
	<pubDate>
	, 02 m 2009 09:45:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975593.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975445.do</link>
	<title>Periodontitis and CHD: First evidence of a genetic link </title>
	<description>
	
	   <![CDATA[ German scientists have for the first time identified a genetic link between periodontitis and coronary heart disease, two conditions characterized by a chronic inflammatory process.  ]]>
	
	</description>
	<pubDate>
	 , 01 m 2009 13:00:56 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975445.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975315.do</link>
	<title>AHA/ASA science advisory recommends use of tPA between three and 4.5 hours after stroke</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH ADDITONAL COMMENTARY</i></b> // A new science advisory from the American Heart Association/American Stroke Association has given the green light to the use of tPA to treat stroke between three and 4.5 hours after symptom onset.   ]]>
	
	</description>
	<pubDate>
	 , 01 m 2009 12:00:17 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975315.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975249.do</link>
	<title>No benefit of compression stockings in DVT prevention after stroke</title>
	<description>
	
	   <![CDATA[ Results of the CLOTS-1 trial show no benefit from use of graduated compression stockings to prevent proximal deep vein thrombosis in patients immobilized by stroke.   ]]>
	
	</description>
	<pubDate>
	, 29  2009 18:15:24 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975249.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975179.do</link>
	<title>Call to cardiac screen all family members of sudden-death victims </title>
	<description>
	
	   <![CDATA[ In the largest study of its kind to date, researchers at a specialized cardiogenetics center in the Netherlands have screened the close families of sudden-unexplained-death victims and found that a third of them are affected by inherited heart disease. ]]>
	
	</description>
	<pubDate>
	, 29  2009 17:15:13 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975179.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975147.do</link>
	<title>APPRAISE with apixaban and STARR with rosiglitazone and ramipril published</title>
	<description>
	
	   <![CDATA[ The APPRAISE and STARR trials, both presented at international cardiology meetings in the past two years, are now published in <i>Circulation</i> and the <i>Journal of the American College of Cardiology</i>, respectively. ]]>
	
	</description>
	<pubDate>
	, 29  2009 16:30:31 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975147.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975095.do</link>
	<title>ICSS: Carotid endarterectomy superior to stenting, at least in the short term</title>
	<description>
	
	   <![CDATA[ Safety data from the first 30 days after these procedures show patients had lower rates of any stroke, MI, or death when treated with endarterectomy vs stenting.  ]]>
	
	</description>
	<pubDate>
	, 29  2009 16:00:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975095.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/975009.do</link>
	<title>FDA gives go-ahead to second paclitaxel-eluting stent for small-diameter coronaries </title>
	<description>
	
	   <![CDATA[  ]]>
	
	</description>
	<pubDate>
	, 29  2009 12:45:34 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/975009.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974923.do</link>
	<title>FDA puts rivaroxaban decision on hold, seeks further information</title>
	<description>
	
	   <![CDATA[ The agency has asked Ortho-McNeil for more information on the oral anticoagulant, which received an advisory-panel blessing in March, but isn't requiring further studies.  ]]>
	
	</description>
	<pubDate>
	, 29  2009 11:45:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974923.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974773.do</link>
	<title>PHIRST published, and tadalafil approved for pulmonary arterial hypertension</title>
	<description>
	
	   <![CDATA[ Tadalafil is a phosphodiesterase type-5 inhibitor and is now available in the 40-mg dose for the purpose of increasing exercise capacity in patients with WHO class 1 PAH. ]]>
	
	</description>
	<pubDate>
	Ϋ, 28  2009 16:30:53 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974773.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974725.do</link>
	<title>Fit but huge, NFL players show normal array of CV risk factors</title>
	<description>
	
	   <![CDATA[ Despite their considerable size, they apparently have a cardiovascular risk profile that's normal for men of similar age in the overall population; they may have more hypertension but are less likely to be glucose intolerant, a study suggests.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 28  2009 13:00:28 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974725.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974679.do</link>
	<title>Naproxen best NSAID for heart-disease patients </title>
	<description>
	
	   <![CDATA[ One of the first large studies to look at the safety of different NSAIDs specifically in patients with heart disease has found that naproxen appears to have better cardiovascular safety than diclofenac, ibuprofen, and higher doses of rofecoxib and celecoxib.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 28  2009 09:30:48 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974679.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974647.do</link>
	<title>FDA approves tolvaptan for hyponatremia</title>
	<description>
	
	   <![CDATA[ The Food and Drug Administration has approved tolvaptan, a selective vasopressin-receptor antagonist that can be taken orally, for the treatment of patients with clinically significant hypervolemic and euvolemic hyponatremia, ]]>
	
	</description>
	<pubDate>
		, 27  2009 17:00:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974647.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974581.do</link>
	<title>SADHART: Increased mortality in severely depressed ACS patients</title>
	<description>
	
	   <![CDATA[ A new seven-year analysis reveals that patients who fail to recover from depression after an acute coronary event are also more likely to die than those who regain their psychological health. ]]>
	
	</description>
	<pubDate>
		, 27  2009 12:00:53 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974581.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974465.do</link>
	<title>Statin therapy after first stroke reduces recurrence and improves mortality</title>
	<description>
	
	   <![CDATA[ Given the global burden of cerebrovascular disease, which affects almost all population groups, the potential benefits of statins cannot be overlooked, according to the investigators.  ]]>
	
	</description>
	<pubDate>
		, 27  2009 10:30:07 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974465.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/974089.do</link>
	<title>Any delay in door-to-balloon time associated with increased in-hospital mortality</title>
	<description>
	
	   <![CDATA[ The data suggest there is no "floor" to the mortality reduction that can be achieved by reducing time to treatment, say investigators, who recommend further reductions in door-to-balloon times. ]]>
	
	</description>
	<pubDate>
	 , 25  2009 17:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/974089.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973901.do</link>
	<title>DATE registry: Three months of clopidogrel for Endeavor? Plus, Xience SPIRIT V</title>
	<description>
	
	   <![CDATA[ At one year, TLR rates in the Korean registry were 4.1%, with very low rates of death (0.6%), AMI (0.4%), stroke (0.5%), and stent thrombosis (0.4%). Experts say the results are encouraging, but not enough to justify shortening dual antiplatelet therapy duration with this device. ]]>
	
	</description>
	<pubDate>
	 , 25  2009 08:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973901.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973837.do</link>
	<title>Same-day carotid stenting and CABG safe and feasible in patients with severe disease</title>
	<description>
	
	   <![CDATA[ Investigators suggest that the simplified operative management strategy of stenting plus CABG can minimize the negative impact of diffuse atherosclerotic disease. ]]>
	
	</description>
	<pubDate>
	, 22  2009 17:15:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973837.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973643.do</link>
	<title>Give blood pressure drugs to all</title>
	<description>
	
	   <![CDATA[ Law and Wald, the duo that brought the world the polypill, now urge that everyone "over a certain age" be put on antihypertensive medication to lower their blood pressure, even if it's normal, to ward off cardiovascular disease and stroke.  ]]>
	
	</description>
	<pubDate>
	, 22  2009 15:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973643.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973297.do</link>
	<title>SYNTAX tool unveiled at EuroPCR: Now the trick is to use it </title>
	<description>
	
	   <![CDATA[ Cheerfully dubbed "a resource for communication between physicians," the SYNTAX "angiographic tool" is meant to help physicians, surgeons, and patients decide on whether stent or surgery is best for their particular flavor of complex coronary artery disease. ]]>
	
	</description>
	<pubDate>
	, 22  2009 10:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973297.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973225.do</link>
	<title>MADIT-2 at eight years: Further ICD survival gains, signs of improved cost-effectiveness </title>
	<description>
	
	   <![CDATA[ Mortality continued to drop in patients with primary-prevention defibrillators, even after they showed a significant survival benefit out to four years, suggests a post hoc analysis of the seminal trial.  ]]>
	
	</description>
	<pubDate>
	, 22  2009 09:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973225.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/973171.do</link>
	<title>Intensive glucose control reduces MI and CHD-event risk, new meta-analysis shows</title>
	<description>
	
	   <![CDATA[ The findings, which include five of the pivotal diabetes studies that have caused a stir regarding glucose control, support continued therapy that lowers elevated glycated hemoglobin A<sub>1c</sub> to less than 7.0%, say researchers. ]]>
	
	</description>
	<pubDate>
	Ϋ, 21  2009 18:30:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/973171.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972985.do</link>
	<title>Genotyping info now in US clopidogrel label </title>
	<description>
	
	   <![CDATA[ The label has been updated to include additional information on factors affecting patients' responses to the drug, including a new section on pharmacogenetics and advice that concomitant use of drugs that inhibit the CYP2C19 enzyme, such as omeprazole, should be discouraged.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 21  2009 15:00:09 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972985.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972665.do</link>
	<title>Incremental updates from transcatheter-valve registries can scarcely keep up with physician interest </title>
	<description>
	
	   <![CDATA[ Not even a 50% one-year mortality rate seen for the transapical approach in the PARTNER EU registry is dampening enthusiasm for the Sapien valve or for the transfemoral-only CoreValve and the up-and-coming devices still in development.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 21  2009 09:20:41 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972665.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972609.do</link>
	<title>More follow-up on the Watchman LAA closure device</title>
	<description>
	
	   <![CDATA[ Investigators presented extended follow-up data for the Watchman left atrial appendage closure device and showed similar results to the overall study findings. They hinted that the confidence intervals are narrowing with longer follow-up, suggesting the device might prove superior to warfarin with sufficient patient-years accrued. ]]>
	
	</description>
	<pubDate>
		, 20  2009 17:30:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972609.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972401.do</link>
	<title>TIMACS published, supports early intervention in high-risk non-STEMI ACS</title>
	<description>
	
	   <![CDATA[ "Early" and "delayed" intervention was similarly effective and safe in the primary analysis, but the subgroup of "high-risk" patients did much better with early intervention; the randomized trial had been previously reported at meetings. ]]>
	
	</description>
	<pubDate>
		, 20  2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972401.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972259.do</link>
	<title>DES in AMI: Some reassurances, more questions from TYPHOON and STRATEGY </title>
	<description>
	
	   <![CDATA[ Longer-term results from these two relatively small randomized trials are reassuring but not sufficient to provide a full rationale for using DES in AMI, experts say.  ]]>
	
	</description>
	<pubDate>
		, 20  2009 13:30:33 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972259.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972151.do</link>
	<title>New HRS/EHRA recommendations for ablation of ventricular arrhythmias </title>
	<description>
	
	   <![CDATA[ The consensus statement is intended to clarify important issues, such as indications, techniques, and outcomes, so that patient care can be optimized and areas of improvement identified. ]]>
	
	</description>
	<pubDate>
		, 20  2009 13:00:18 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972151.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/972065.do</link>
	<title>Chewable aspirin best for ACS: Small study supports guidelines </title>
	<description>
	
	   <![CDATA[ A small study in 14 healthy volunteers has shown that chewable aspirin is absorbed more efficiently and rapidly than regular aspirin, whether it is swallowed whole or chewed first. The research is the first to directly compare different formulations and supports current guidelines that chewing aspirin is the preferential method of administration in the treatment of ACS, say the investigators.  ]]>
	
	</description>
	<pubDate>
		, 20  2009 12:00:40 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/972065.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971885.do</link>
	<title>Large meta-analysis links higher levels of cardiorespiratory fitness to lower risk of death and cardiovascular disease</title>
	<description>
	
	   <![CDATA[ The higher the level of cardiorespiratory fitness, the lower the risk of death and cardiovascular disease in this large meta-analysis from Japanese researchers. ]]>
	
	</description>
	<pubDate>
	, 19  2009 17:15:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971885.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971833.do</link>
	<title>Intramyocardial bone-marrow injection for chronic ischemia </title>
	<description>
	
	   <![CDATA[ A small, short-term, phase 2 study examining intramyocardial injection of autologous bone-marrow cells in patients suffering from chronic myocardial ischemia has shown encouraging results. But the researchers say further studies are needed to assess the long-term results and efficacy for mortality and morbidity.  ]]>
	
	</description>
	<pubDate>
	, 19  2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971833.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971717.do</link>
	<title>The return of the reservoir DES: Nevo stent impresses against Taxus at six months </title>
	<description>
	
	   <![CDATA[ Early results for the novel stent are reviving hopes for a concept that many people agreed was a good idea to begin with&#151;reservoir-based elution of an antiproliferative drug, using a bioerodable polymer.  ]]>
	
	</description>
	<pubDate>
	, 19  2009 14:30:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971717.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971563.do</link>
	<title>Pooled five-year results for Endeavor support durability of TLR, low adverse events </title>
	<description>
	
	   <![CDATA[ The findings should help quell fears of a late catch-up phenomenon with a stent some have referred to as "DES-lite" and dispel concerns raised in meeting presentations last year about increased adverse events with this device.  ]]>
	
	</description>
	<pubDate>
	, 19  2009 12:00:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971563.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971359.do</link>
	<title>Eliminating cyclophilin A gene protects against abdominal aortic aneurysm </title>
	<description>
	
	   <![CDATA[ Deficiency of cyclophilin A decreases inflammation, oxidative stress, and matrix degradation in mouse models of aortic aneurysm formation, a new study suggests.  ]]>
	
	</description>
	<pubDate>
	 , 18  2009 17:30:33 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971359.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971381.do</link>
	<title>US registry points to substantial risk from ICD, pacemaker replacement </title>
	<description>
	
	   <![CDATA[ Preliminary numbers covering more than 1000 device change-outs put the major complication rates at 6% for ICDs and 2.5% for pacemakers.   ]]>
	
	</description>
	<pubDate>
	 , 18  2009 17:30:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971381.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971299.do</link>
	<title>Obesity paradox probed in new review</title>
	<description>
	
	   <![CDATA[ Obesity is a key cause of multiple forms of heart disease but paradoxically seems to boost survival in heart failure, hypertension, and coronary and peripheral artery disease. But according to a new review, losing weight remains beneficial, even in obese patients whose excess weight appears advantageous.  ]]>
	
	</description>
	<pubDate>
	 , 18  2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971299.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971335.do</link>
	<title>Antihypertensive use in pregnancy: No clear-cut answer on risk of congenital heart defects</title>
	<description>
	
	   <![CDATA[ One of the largest case-control studies of its kind has found that medication for high blood pressure used during pregnancy might increase the risk of congenital heart defects. But the researchers urge caution in interpreting their findings, noting that further research is needed to confirm or refute the results. ]]>
	
	</description>
	<pubDate>
	 , 18  2009 13:15:47 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971335.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971267.do</link>
	<title>Subcutaneous ICD system detects and terminates induced ventricular fibrillation </title>
	<description>
	
	   <![CDATA[ There is hope, say investigators, that the advantages of the device, which is eight years in development, might lower the risk barriers for some patients indicated for ICD therapy and increase referrals and patient acceptance.  ]]>
	
	</description>
	<pubDate>
	 , 18  2009 10:30:02 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971267.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/971237.do</link>
	<title>High, low estradiol levels linked to mortality in men with chronic systolic heart failure </title>
	<description>
	
	   <![CDATA[ Those in the highest and lowest estradiol quintiles at baseline also differed with respect to some characteristics in ways that might shed light on why their risk was increased.   ]]>
	
	</description>
	<pubDate>
	 , 18  2009 10:00:15 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/971237.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970995.do</link>
	<title>ATHENA data suggest dronedarone for AF is safe in stable heart failure </title>
	<description>
	
	   <![CDATA[ A post hoc analysis could help alleviate a lingering concern about the drug, which an FDA advisory panel recently recommended for approval.   ]]>
	
	</description>
	<pubDate>
	m, 16  2009 08:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970995.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970807.do</link>
	<title>Dr Eric Topol one of GQ magazine&#39;s &quot;Rock Stars of Science&quot;</title>
	<description>
	
	   <![CDATA[ The six-page photo spread includes leading US scientists posing with celebrity rock legends, including Sheryl Crow and Seal.  ]]>
	
	</description>
	<pubDate>
	, 15  2009 15:30:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970807.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970867.do</link>
	<title>Budiodarone reduces atrial-fibrillation burden in phase 2 study</title>
	<description>
	
	   <![CDATA[ The drug is a chemical analog of amiodarone, and investigators say it is "user friendly," with good efficacy and a positive side-effect profile. Larger, definitive studies, however, are still needed. ]]>
	
	</description>
	<pubDate>
	, 15  2009 15:00:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970867.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970733.do</link>
	<title>DASH diet reduces risk of heart failure </title>
	<description>
	
	   <![CDATA[ Women who had a food intake similar to the DASH diet, with high consumption of fruits, vegetables, and whole grains and a low intake of fat and dairy products, had a reduced risk of developing heart failure in a recent study.  ]]>
	
	</description>
	<pubDate>
	, 15  2009 14:00:25 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970733.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970637.do</link>
	<title>MI rates drop after decline in HRT use post-WHI </title>
	<description>
	
	   <![CDATA[ A new study using the general US population has found that the sharp drop in use of hormone-replacement therapy in the three years from 2002 onward was associated with significantly fewer MIs among women, but that the stroke rate was unaffected.  ]]>
	
	</description>
	<pubDate>
	, 15  2009 12:15:29 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970637.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970449.do</link>
	<title>Pulmonary vein isolation plus substrate ablation best for reducing AF </title>
	<description>
	
	   <![CDATA[ An ablation strategy that combines pulmonary vein isolation with substrate-based ablation works best for eliminating atrial fibrillation at one year when compared with ablation techniques targeting only the pulmonary veins or substrate, a new study has shown. ]]>
	
	</description>
	<pubDate>
	, 15  2009 10:05:33 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970449.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970361.do</link>
	<title>ALTITUDE: Survival with primary-prevention ICDs better than ever in remotely monitored &quot;real-world&quot; population</title>
	<description>
	
	   <![CDATA[ High survival rates in the analysis may reflect contemporary clinical practice more accurately than do the clinical trials that established primary-prevention defibrillator therapy, researchers say.   ]]>
	
	</description>
	<pubDate>
	, 15  2009 08:45:51 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970361.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970183.do</link>
	<title>The obesity epidemic in the US is due solely to increased food intake</title>
	<description>
	
	   <![CDATA[ The rise in obesity in the US since the 1970s is entirely due to increased food consumption, not to a lack of physical activity. If Americans truly want to win the battle of the bulge, they are going to have to cut down on the amount of food they currently consume. ]]>
	
	</description>
	<pubDate>
	Ϋ, 14  2009 17:00:38 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970183.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/970309.do</link>
	<title>No complications, no overheating with MRI-compatible pacemaker and leads</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Patients with pacemakers are not allowed in an MR scanner because of concerns about induced arrhythmias and overheated leads, but this study showed no complications and no changes in temperature at the tip of the lead. Investigators say this is good news, considering the growing number of pacemaker-implanted patients who require an MRI scan.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 14  2009 16:40:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/970309.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969975.do</link>
	<title>HRS urges upgrades to process of recognition, reporting of ICD lead performance issues</title>
	<description>
	
	   <![CDATA[ One crucial goal of the newly minted document is to foster realistic expectations for lead capabilities among regulators, industry, clinicians, and even patients.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 14  2009 09:15:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969975.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969833.do</link>
	<title>New HRS consensus statement on lead extraction sets volume benchmarks for operators</title>
	<description>
	
	   <![CDATA[ Physicians trained in lead extraction should extract a minimum of 40 leads as the primary operator under the supervision of a qualified training physician and should extract a minimum of 20 leads annually as the lead operator. These numbers, however, are a "bare-bones" minimum, say researchers, stressing that patient care should always be individualized.   ]]>
	
	</description>
	<pubDate>
		, 13  2009 16:40:47 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969833.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969789.do</link>
	<title>No significant reduction of CV events with aspirin in peripheral artery disease</title>
	<description>
	
	   <![CDATA[ A meta-analysis of trials assessing the effects of aspirin with or without dipyridamole in patients with PAD finds no significant benefit in reducing overall cardiovascular events, although there was a significant reduction in stroke as a secondary end point. ]]>
	
	</description>
	<pubDate>
		, 13  2009 16:30:40 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969789.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969721.do</link>
	<title>New antiplatelet ticagrelor could challenge clopidogrel, prasugrel </title>
	<description>
	
	   <![CDATA[ AstraZeneca says its new reversible antiplatelet agent, ticagrelor, was more effective at preventing MI/stroke/cardiovascular death than clopidogrel in the phase 3 PLATO trial. Full results will be revealed at European Society of Cardiology meeting in Barcelona, but the new drug could rival clopidogrel or, more especially, prasugrel. ]]>
	
	</description>
	<pubDate>
		, 13  2009 14:30:53 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969721.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969693.do</link>
	<title>CHAMPION trials with cangrelor stopped for lack of efficacy </title>
	<description>
	
	   <![CDATA[ The trials' interim analysis review committee has decided that the study would not demonstrate the "persuasive" clinical efficacy needed for regulatory approval.   ]]>
	
	</description>
	<pubDate>
		, 13  2009 13:15:16 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969693.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969515.do</link>
	<title>Low fracture rate, clinical improvements with Zilver stent for peripheral artery disease </title>
	<description>
	
	   <![CDATA[ In an interim analysis, the stent appeared to reduce revascularization rates and improve Rutherford score, walk distance, and walk score. A randomized trial completed enrollment last year.  ]]>
	
	</description>
	<pubDate>
		, 13  2009 11:30:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969515.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969445.do</link>
	<title>Lower blood pressure, not the drug regimen, regresses left ventricular hypertrophy</title>
	<description>
	
	   <![CDATA[ These new data support the concept that previously described differences in LVH regression between antihypertensive agents are abolished when recommended blood-pressure goals are achieved, say researchers. ]]>
	
	</description>
	<pubDate>
		, 13  2009 10:15:12 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969445.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969215.do</link>
	<title>Delays to treatment similar for radial and femoral PCI in STEMI patients </title>
	<description>
	
	   <![CDATA[ Provided operators have the training and experience, there's no reason STEMI patients can't be treated via a transradial approach, and there may even be advantages to doing so, several reports suggest.  ]]>
	
	</description>
	<pubDate>
	, 12  2009 15:45:39 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969215.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969101.do</link>
	<title>Risk-factor modification is goal of cardiac rehab program that emphasizes burning calories </title>
	<description>
	
	   <![CDATA[ Patients are told to "walk often and walk far." On the "high-calorie-expenditure" rehab program, they lost more weight and significantly improved their cardiometabolic risk-factor profile compared with patients in a more traditional program. ]]>
	
	</description>
	<pubDate>
	, 12  2009 12:45:55 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969101.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/969055.do</link>
	<title>ACC, ASA, and AHA implore clinicians to enroll patients in PFO trials</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Unless more patients are directed into one of four ongoing studies, the real value of the procedure&#151;if any&#151;may never be properly established, a new scientific advisory warns.  ]]>
	
	</description>
	<pubDate>
	, 12  2009 10:30:14 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/969055.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968855.do</link>
	<title>Device closure of PFO &quot;tunnel&quot; may offer advantages over double-disk occluders </title>
	<description>
	
	   <![CDATA[ Results are early and in limited numbers, but experts say the Coherex FlatStent, deployed just in the area of overlap between the septum primum and the septum secundum, is a promising new addition to the field. ]]>
	
	</description>
	<pubDate>
	 , 11  2009 17:15:58 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968855.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968741.do</link>
	<title>First hint of a benefit for statins in rheumatic valve disease </title>
	<description>
	
	   <![CDATA[ A new retrospective echocardiography study has shown, for the first time, that statins might reduce the progression of aortic-valve stenosis caused by rheumatic heart disease. But the findings require confirmation, says an accompanying editorial.  ]]>
	
	</description>
	<pubDate>
	 , 11  2009 17:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968741.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968715.do</link>
	<title>New AHA/ASA guidelines on TIA management and telemedicine in acute stroke released</title>
	<description>
	
	   <![CDATA[ The American Heart Association/American Stroke Association has released two new guideline documents, one providing a new definition of transient ischemic attacks and advocating urgent treatment and the other giving a green light to use of telemedicine consults in acute stroke assessment.     ]]>
	
	</description>
	<pubDate>
	 , 11  2009 14:45:04 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968715.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968701.do</link>
	<title>Somatic depressive symptoms predict worse CVD outcomes in women</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH </i></b><b><i>COMMENTARY</i></b> // Women with suspected myocardial ischemia who also have somatic depressive symptoms are likely to have worse outcomes than women without depression, However, those with cardiovascular disease and cognitive/affective depressive symptoms do not appear to share this increased risk, new research shows.  ]]>
	
	</description>
	<pubDate>
	 , 11  2009 13:45:12 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968701.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968497.do</link>
	<title>Dual-acting receptor antagonist superior to ARB for treatment of hypertension</title>
	<description>
	
	   <![CDATA[ After 12 weeks of treatment with a dual-acting receptor antagonist, 60% of patients treated with the highest dose of the agent achieved blood-pressure control, whereas just 32% of patients treated with high-dose irbesartan achieved the same degree of control. ]]>
	
	</description>
	<pubDate>
	 , 11  2009 12:45:08 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968497.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968549.do</link>
	<title>New studies identify genetic variants associated with blood pressure and hypertension</title>
	<description>
	
	   <![CDATA[ Investigators who presented their results separately identified 13 genes associated with systolic and diastolic blood pressure.  ]]>
	
	</description>
	<pubDate>
	 , 11  2009 11:45:50 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968549.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968461.do</link>
	<title>ACCOMPLISH: Systolic blood pressure with 24-hour monitoring no different in treatment arms</title>
	<description>
	
	   <![CDATA[ Investigators say the results support their earlier conclusions that the difference in morbidity and mortality was driven by a more effective combination therapy with the ACE inhibitor benazepril plus the calcium-channel blocker amlodipine and not by differences in blood pressure. ]]>
	
	</description>
	<pubDate>
	 , 11  2009 10:00:48 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968461.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968343.do</link>
	<title>Fix and ship: No mortality penalty when STEMI patients transferred back to referring hospitals post-PCI </title>
	<description>
	
	   <![CDATA[ A unique strategy of "repatriating" stable STEMI patients back to their referring hospitals post-PCI has no downside in terms of mortality and may help hospitals improve door-to-balloon times, clear out their PCI wards, and share the burden&#151;and rewards&#151;of patient care.  ]]>
	
	</description>
	<pubDate>
	m, 09  2009 09:00:42 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968343.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968273.do</link>
	<title>Stent studies hit print: DES positions fortified in SCAAR, HORIZONS-AMI, and Ontario registry</title>
	<description>
	
	   <![CDATA[ Three studies published this week strengthen the case for preferring drug-eluting stents over bare-metal stents in a number of clinical and anatomic settings.  ]]>
	
	</description>
	<pubDate>
	, 08  2009 18:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968273.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968179.do</link>
	<title>Gene variants affecting response to clopidogrel not a factor with prasugrel </title>
	<description>
	
	   <![CDATA[ The genetic variant that appears to confer resistance to clopidogrel does not seem to affect patient response to prasugrel, according to the first analysis to specifically examine this issue.  ]]>
	
	</description>
	<pubDate>
	, 08  2009 17:00:37 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968179.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/968025.do</link>
	<title>Konstam offers new details on his role in Vioxx meta-analysis </title>
	<description>
	
	   <![CDATA[ Dr Marvin Konstam has countered allegations that he did not significantly contribute to a 2001 <i>Circulation</i> paper on rofecoxib, despite the fact he was its lead author, as reported by <b>heart</b><b><i>wire</i></b> last week.  ]]>
	
	</description>
	<pubDate>
	, 08  2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/968025.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967769.do</link>
	<title>Return of the J-curve: TNT analysis shows that BP can be too low in CAD patients</title>
	<description>
	
	   <![CDATA[ In a group of patients with coronary artery disease, despite substantial lowering of LDL-cholesterol levels, a J-curve relationship exists between systolic and diastolic blood pressure and cardiovascular events, suggesting that low blood pressure can be harmful. ]]>
	
	</description>
	<pubDate>
	, 08  2009 11:15:04 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967769.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967645.do</link>
	<title>AMADEUS: Percutaneous mitral annuloplasty device shows promise at six months </title>
	<description>
	
	   <![CDATA[ The device can be deployed within 60 minutes and appears to be a safe and effective option for patients with mitral-valve regurgitation too sick for open-heart procedures, results from the 30-patient trial show. ]]>
	
	</description>
	<pubDate>
	Ϋ, 07  2009 17:30:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967645.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967419.do</link>
	<title>In brief: Biosite recalls cardiac marker test, FDA warns about Baxter sealant</title>
	<description>
	
	   <![CDATA[ One lot of a Biosite test to aid in diagnosis of MI has been voluntarily recalled by the company due to quality-control problems. Meantime, the FDA has warned Baxter about misleading promotional materials for its fibrin sealant, Tisseel.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 07  2009 14:30:11 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967419.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967383.do</link>
	<title>Stent thrombosis responsible for an increasing proportion of STEMI </title>
	<description>
	
	   <![CDATA[ The regional study highlights the need for studies addressing whether stent-thrombosis-STEMI patients should be treated the same as other STEMI patients.  ]]>
	
	</description>
	<pubDate>
	Ϋ, 07  2009 13:15:14 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967383.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967229.do</link>
	<title>Most hypertension drugs, except ARBs, better than no treatment for CHD risk reduction</title>
	<description>
	
	   <![CDATA[ Although most patients receive more than one drug for high blood pressure, two new meta-analyses show that, in terms of initial drug therapy, only angiotensin receptor blockers were not significantly better than placebo or no treatment for the prevention of coronary heart disease events, while all antihypertensive drugs were better than placebo for the prevention of stroke. ]]>
	
	</description>
	<pubDate>
	Ϋ, 07  2009 09:30:44 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967229.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/967075.do</link>
	<title>Possible &quot;class effect&quot; for proton-pump inhibitors on top of clopidogrel therapy</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // One-year risk of cardiovascular events is 50% higher in patients taking a proton-pump inhibitor on top of clopidogrel and similar for four PPIs, according to a retrospective cohort study of more than 16 700 patients who received clopidogrel poststenting.  ]]>
	
	</description>
	<pubDate>
		, 06  2009 17:15:49 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/967075.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966981.do</link>
	<title>Blacks more likely to have AF than previously thought? </title>
	<description>
	
	   <![CDATA[ A new study has found that African Americans seem to have more abnormal values of atrial-fibrillation predictors on ECG than whites, which might help explain why they are at higher risk of ischemic stroke than whites, despite apparently having a lower prevalence of AF.  ]]>
	
	</description>
	<pubDate>
		, 06  2009 12:30:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966981.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966959.do</link>
	<title>No link between hypoglycemia and mortality or stroke/MI in diabetic AMI patients: DIGAMI-2 analysis</title>
	<description>
	
	   <![CDATA[ The study is the latest to turn the spotlight off hypoglycemia as a risk factor and instead find fault with other comorbidities.   ]]>
	
	</description>
	<pubDate>
		, 06  2009 11:15:21 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966959.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966855.do</link>
	<title>Reperfusion markers at primary PCI seen to predict short-term arrhythmic risk </title>
	<description>
	
	   <![CDATA[ Most VT/VF after PCI for STEMI occurred within the first two days of the procedure, in a retrospective analysis of &gt;5000 patients followed for 90 days.  ]]>
	
	</description>
	<pubDate>
		, 06  2009 10:15:22 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966855.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966827.do</link>
	<title>Merck begins defense in Vioxx case in Australia </title>
	<description>
	
	   <![CDATA[ Lawyers for Merck began their defense this week in the rofecoxib class-action lawsuit that is ongoing in Australia. They will have to counter many astonishing allegations that have been made in court in Melbourne over the past few weeks.  ]]>
	
	</description>
	<pubDate>
		, 06  2009 09:30:30 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966827.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966763.do</link>
	<title>Microalbuminuria predicts VTE in population-based study</title>
	<description>
	
	   <![CDATA[ Although microalbuminuria is known to predict increased risk for arterial thromboembolism, researchers analyzing data from the PREVEND study showed for the first time that it may also predict venous thromboembolism. ]]>
	
	</description>
	<pubDate>
	, 05  2009 16:00:00 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966763.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966657.do</link>
	<title>RECORD4 published: Rivaroxaban superior to enoxaparin in VTE prevention </title>
	<description>
	
	   <![CDATA[ In the fourth study in this series, the new oral anticoagulant looked more effective than enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty.  ]]>
	
	</description>
	<pubDate>
	, 05  2009 15:45:05 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966657.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966577.do</link>
	<title>Family docs and internists mistakenly think they do fine treating high blood pressure</title>
	<description>
	
	   <![CDATA[ A small survey of family doctors and general internists reveals that while they think they're doing a good job of treating high blood pressure, the reality does not quite jibe with their opinion.  ]]>
	
	</description>
	<pubDate>
	, 05  2009 15:00:24 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966577.do</guid>
	</item>


	<item>
	<link>http://www.theheart.org/article/966459.do</link>
	<title>CMS on warfarin-responsiveness genetic test: No Medicare coverage except within trials</title>
	<description>
	
	   <![CDATA[  ]]>
	
	</description>
	<pubDate>
	, 05  2009 09:00:36 EDT
	</pubDate>
	<guid>http://www.theheart.org/article/966459.do</guid>
	</item>

</channel>
</rss>

